ESSA Pharma Inc. (EPIX)
- Previous Close
1.7100 - Open
1.7100 - Bid 1.7000 x 400
- Ask 1.7700 x 100
- Day's Range
1.6900 - 1.7600 - 52 Week Range
1.4000 - 7.8800 - Volume
81,633 - Avg. Volume
193,221 - Market Cap (intraday)
76.348M - Beta (5Y Monthly) 1.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6900 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.70
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.
www.essapharma.comRecent News: EPIX
View MorePerformance Overview: EPIX
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EPIX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EPIX
View MoreValuation Measures
Market Cap
76.79M
Enterprise Value
-43.35M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.65
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-17.08%
Return on Equity (ttm)
-23.98%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-31.11M
Diluted EPS (ttm)
-0.6900
Balance Sheet and Cash Flow
Total Cash (mrq)
120.55M
Total Debt/Equity (mrq)
0.26%
Levered Free Cash Flow (ttm)
-13.96M